Urologix (ULGX) 0.0326 $ULGX Global Prostrate Specific

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Urologix (ULGX) 0.0326 $ULGX

Global Prostrate Specific Antigen (PSA) Testing Market Analysis 2015-2020 - Free PSA Test, Complex PSA Test, Reverse PCR Test
M2 - Thu Sep 10, 4:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n53fd7/prostrate) has announced the addition of the "Prostrate Specific Antigen (PSA) Testing Market Analysis (2015 - 2020); By Type (Free PSA Test, Complex PSA Test, Reverse PCR Test); By Geography (North America, Europe, APAC)" report to their offering. The PSA testing is gaining popularity among clinicians and hospitals as the number of people affected by prostate cancer in the age bracket of 40-50 years is on a rise. A high level of PSA is an indicator of possible prostate cancer. However, there are other physical conditions which might lead to an increase in PSA levels. The number of people affected by prostate cancer in 2014 was 233,000 from 417,000 in 2012. The reason for this sharp decline in prostate cancer incidences is due to effective PSA testing. The global PSA testing market was close to $250 million in 2014. The population in the age bracket of 50-64 years are more likely to develop prostate cancer. Prostate Cancer is the fourth most common cancer. The need for PSA testing has seen an upward surge. The North America region is going to see the highest increase due to better focus on healthcare. The Europe region has different guidelines and policies for PSA testing in different countries. Such scenario has led to a decreased use of PSA testing in Europe region. Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the PSA testing market and future opportunities are provided in the report. This report on the global PSA testing market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the PSA testing market. Key Topics Covered: 1. PSA Testing Market Overview 2. Executive Summary 3. PSA Testing Market Landscape 4. PSA Testing Market Forces 5. PSA Testing Market - Strategic Analysis 6. PSA Testing Market - By Type 7. Global PSA Testing Market - Geographic Analysis 8. Market Entropy 9. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio) 10. Appendix Companies Mentioned - Abbott Laboratories, Inc. - Bayer AG - Beckman Coulter, Inc. - GE Helathcare - GlaxoSmithKline, plc. - Novartis Pharma AG. - UroLogix, Inc. - Bristol - Myers Squibb Company - AstraZeneca plc. - Johnson & Johnson Diagnostics - BioChem Pharma - Pharmacia Delfia - Roche Diagnostics - Olympus - Tosho For more information visit http://www.researchandmarkets.com/research/n53fd7/prostrate
JNJ: 95.37 (+0.29), ABT: 41.89 (+0.73), AZN: 32.23 (-0.16), GSK: 40.22 (+0.06), NVS: 91.90 (-0.71)

Urologix Announces SEC Deregistration
GlobeNewswire - Thu Jul 09, 3:00PM CDT
Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced its decision to terminate and suspend the registration of its stock with the Securities and Exchange Commission (the "SEC" . The Company also intends to cause its common stock to cease trading on the OTCQB and commence trading on the OTC Pink marketplace. For more information about the OTC Pink marketplace, please see www.otcmarkets.com.

Costs for In-Office BPH Therapies Presented at the AUA 2015 Annual Meeting in New Orleans
GlobeNewswire - Thu May 21, 3:00PM CDT
Urologix, Inc. (OTCQB:ULGX), a market leader for the in-office treatment of benign prostatic hyperplasia (BPH) today announced that data highlighting the costs and outcomes of cooled high energy Transurethral Microwave Therapy (HE-TUMT), Transurethral Needle Ablation (TUNA), and the Prostatic Urethral Lift (PUL) were the topic of a podium presentation this past weekend at the American Urological Association (AUA) 2015 Annual Meeting held in New Orleans, LA.

Urologix's (ULGX) CEO Greg Fluet on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue May 12, 6:40PM CDT


Urologix Products Featured in Cost-Effectiveness Research to be Presented at Upcoming Industry Meeting in New Orleans
GlobeNewswire - Tue May 12, 3:01PM CDT
Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced an upcoming presentation at the American Urological Association (AUA) 2015 annual meeting to be held May 15-18, 2015 in New Orleans, LA.

Next Week In Biotech: ASCO Abstracts, Pernix PDUFA, Celladon Earnings
SA Editor Mike Taylor - Seeking Alpha - Fri May 08, 8:00AM CDT
Biotech investors have plenty to look forward to next week, as the American Society of Clinical Oncology will release presentation abstracts for its upcoming annual meeting, while a PDUFA date is expected for Pernix (NASDAQ: PTX ). Last week's flood...
ARWR: 5.89 (+0.13), CLSN: 1.84 (+0.14), CMRX: 37.40 (-0.19), SCLN: 7.12 (+0.12), ELOS: 7.97 (+0.15), ZGNX: 13.80 (+0.78), LGND: 88.54 (+2.12), DEPO: 19.00 (+0.27), IMUC: 0.44 (-0.01), ARGS: 5.80 (-0.18), OPXA: 3.20 (-0.08), FLML: 18.38 (+0.37), OGXI: 2.26 (+0.07), CTSO: 6.27 (-0.08), DARA: 0.84 (-0.01), ICCC: 6.38 (+0.06), ICPT: 181.90 (-8.81), PBYI: 79.41 (+3.89), BDSI: 6.74 (+0.22), ACT: 298.98 (-2.94), DRNA: 10.05 (+0.88), BSTC: 53.55 (+1.95), PAHC: 31.24 (+0.40), PTX: 3.26 (+0.15), XON: 36.01 (+1.24), FOMX: 6.84 (+0.17), CLDN: 1.12 (+0.03), BIOC: 2.47 (+0.03), CHRS: 23.29 (-0.07), DSCI: 5.35 (+0.25), INO: 6.16 (+0.20), FMI: 19.97 (+0.38), CYTX: 0.42 (+0.02), ANTH: 6.12 (+0.12), ATHX: 1.14 (-0.01), ALQA: 3.56 (+0.03), ENDP: 64.27 (+0.85), DPLO: 26.65 (+1.93), GALT: 2.61 (-0.10), RPRX: 7.81 (+0.05), OMER: 12.66 (+0.58), HALO: 14.37 (+0.08), IDRA: 3.03 (+0.10), CF: 50.78 (-2.08), BTX: 3.41 (-0.09), APRI: 1.65 (+0.03), ATRS: 1.59 (+0.02), KPTI: 11.75 (+0.04)

Urologix to Host Its Fiscal Year 2015 Third Quarter Conference Call
GlobeNewswire - Tue May 05, 3:00PM CDT
Urologix, Inc. (OTCQB:ULGX) will host a conference call to present third quarter fiscal year 2015 results on Tuesday, May 12, 2015 at 4:00 p.m. CT, following the Company's post-market press release on the same day. On the day of the call, please dial 1-877-359-9508 and enter the conference ID 42703418 at least 10 minutes prior to the call. The conference call will be broadcast live over the Internet at www.urologix.com. Greg Fluet, Chief Executive Officer, will host the call.

New finance chief at Urologix
Seeking Alpha - at Seeking Alpha - Mon Mar 23, 11:41AM CDT


Urologix Announces Hiring of Chief Financial Officer
GlobeNewswire - Mon Mar 23, 8:00AM CDT
Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced the appointment of Scott M. Madson as its Chief Financial Officer effective April 1, 2015. Mr. Madson brings over 30 years of both public and private company financial leadership experience to his new role, having most recently provided finance and accounting management consulting services through his company, Madson Consulting LLC. Previously, Scott was Vice President, Controller and Chief Accounting Officer for Universal Hospital Services, Inc, one of the nation's largest providers of mobile medical equipment and healthcare technology management services.

Urologix to Host Its Fiscal Year 2015 Second Quarter Conference Call
GlobeNewswire - Thu Jan 29, 3:00PM CST
Urologix, Inc. (OTCQB:ULGX) will host a conference call to present second quarter fiscal year 2015 results on Thursday, February 5, 2015 at 4:00 p.m. CT, following the Company's post-market press release on the same day. On the day of the call, please dial 1-866-515-2910 and enter the Participant Passcode 37953871 at least 10 minutes prior to the call. The conference call will be broadcast live over the Internet at www.urologix.com. Greg Fluet, Chief Executive Officer, will host the call.

Urologix reports February 5
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 11:08AM CST


Urologix reports FQ1 loss
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:40PM CST


Urologix to Host Its Fiscal Year 2015 First Quarter Conference Call
GlobeNewswire - Tue Oct 28, 3:00PM CDT
Urologix, Inc. (OTCQB:ULGX) will host a conference call to present first quarter fiscal year 2015 results on Tuesday, November 4, 2014 at 4:00 p.m. CT, following the Company's post-market press release on the same day. On the day of the call, please dial 1-866-318-8617 and enter the Participant Passcode 57661939 at least 10 minutes prior to the call. The conference call will be broadcast live over the Internet at www.urologix.com. Greg Fluet, Chief Executive Officer, will host the call.

VigiLanz Names Patrick Spangler as Chief Financial Officer
Business Wire - Tue Sep 09, 7:00AM CDT
VigiLanz, a digital healthcare technology company headquartered in Minneapolis, announced today the appointment of Patrick Spangler as Chief Financial Officer.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 86

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 17

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 0

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 84

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 0

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 28

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 70

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Alliance for Women in Media Champions Change in 2026

Updated Category News Views 39

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 51

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights on E Split Corp. Class A Distribution for Shareholders

Updated Category News Views 147

E Split Corp. Class A Distribution Announcement Toronto-based E Split Corp. (TSX: ENS) is thrilled to share important news with its Class A shareholders regarding the upcoming distribution for October. This is a significant update for investors who are keen on dividend payments made by this dynamic fund. Details of the Distribution This distribution signals the company's...

Continue Reading
Aberdeen Investments: Recent Distribution Insights for Shares

Updated Category News Views 187

Understanding Distribution Payments from Aberdeen Investments Aberdeen Investments U.S. Closed-End Funds, including stocks like ASGI, have announced significant updates regarding their distribution payments. These distributions are crucial for investors as they represent a return on their investments. Released on a recent date, the Funds paid these distributions per share...

Continue Reading
Nuvini Group's Impressive 2025 Financial Performance Review

Updated Category News Views 191

Nuvini Group Report Highlights Growth in 2025 Nuvini Group Limited (NASDAQ: NVNI) is making waves with its impressive financial results for the first half of 2025. This Brazilian venture is recognized as a premier acquirer and operator of business-to-business (B2B) software as a service (SaaS) companies. The company has demonstrated a significant increase in cash flow...

Continue Reading
Exciting Housing Announcement: Key Insights for Communities

Updated Category News Views 156

Anticipating New Housing Developments Media outlets are set to cover an important housing announcement with significant implications for local communities. This event highlights the collaboration between government officials and community leaders focused on addressing housing needs and enhancing infrastructure in various regions. Key Officials Present at the Event The...

Continue Reading
Investors Rally Against Edwards Lifesciences After Losses

Updated Category News Views 72

Edwards Lifesciences Faces Investor Backlash Amidst significant financial turmoil, Edwards Lifesciences Corporation (NYSE: EW) is grappling with a class action lawsuit initiated by concerned investors. This situation emerged after the company witnessed a staggering loss exceeding $16 billion in market capitalization. Investors are understandably anxious as they reflect on...

Continue Reading